Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2466.9 and 2499
| Intraday Target 1 | 2460.57 |
| Intraday Target 2 | 2473.23 |
| Intraday Target 3 | 2492.6666666667 |
| Intraday Target 4 | 2505.33 |
| Intraday Target 5 | 2524.77 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Wed 04 March 2026 | 2485.90 (-1.84%) | 2501.00 | 2480.00 - 2512.10 | 0.9742 times | Mon 02 March 2026 | 2532.60 (-1.52%) | 2520.00 | 2511.70 - 2581.60 | 1.9817 times | Fri 27 February 2026 | 2571.60 (-2.07%) | 2632.10 | 2566.00 - 2633.10 | 0.8663 times | Thu 26 February 2026 | 2626.00 (-1%) | 2650.00 | 2610.00 - 2650.00 | 0.6438 times | Wed 25 February 2026 | 2652.50 (1.31%) | 2602.50 | 2602.50 - 2667.40 | 0.7335 times | Tue 24 February 2026 | 2618.20 (-0.77%) | 2635.10 | 2591.30 - 2635.10 | 1.0739 times | Mon 23 February 2026 | 2638.60 (1.61%) | 2616.80 | 2610.50 - 2668.80 | 1.1032 times | Fri 20 February 2026 | 2596.90 (0.74%) | 2577.00 | 2558.10 - 2610.40 | 0.7279 times | Thu 19 February 2026 | 2577.90 (-0.23%) | 2584.00 | 2560.00 - 2625.00 | 1.0625 times | Wed 18 February 2026 | 2583.80 (-0.76%) | 2603.60 | 2578.60 - 2644.00 | 0.8329 times | Tue 17 February 2026 | 2603.60 (0.24%) | 2590.80 | 2579.00 - 2627.00 | 1.6337 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2432.15 and 2533.75
| Weekly Target 1 | 2414.23 |
| Weekly Target 2 | 2450.07 |
| Weekly Target 3 | 2515.8333333333 |
| Weekly Target 4 | 2551.67 |
| Weekly Target 5 | 2617.43 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Wed 04 March 2026 | 2485.90 (-3.33%) | 2520.00 | 2480.00 - 2581.60 | 0.4248 times | Fri 27 February 2026 | 2571.60 (-0.97%) | 2616.80 | 2566.00 - 2668.80 | 0.6354 times | Fri 20 February 2026 | 2596.90 (0.1%) | 2590.00 | 2558.10 - 2644.00 | 0.703 times | Fri 13 February 2026 | 2594.40 (4.44%) | 2489.00 | 2475.00 - 2719.80 | 1.8222 times | Fri 06 February 2026 | 2484.00 (3.43%) | 2421.40 | 2342.10 - 2489.00 | 0.9318 times | Fri 30 January 2026 | 2401.60 (3.81%) | 2319.00 | 2278.30 - 2442.90 | 0.8262 times | Fri 23 January 2026 | 2313.40 (-1.36%) | 2345.90 | 2220.30 - 2420.00 | 1.0693 times | Fri 16 January 2026 | 2345.40 (-1.13%) | 2372.00 | 2337.60 - 2417.10 | 0.5848 times | Fri 09 January 2026 | 2372.10 (-4.5%) | 2484.90 | 2350.00 - 2528.00 | 0.9927 times | Fri 02 January 2026 | 2483.80 (0.79%) | 2483.00 | 2362.60 - 2487.70 | 2.0099 times | Fri 26 December 2025 | 2464.30 (-2.56%) | 2530.10 | 2459.50 - 2550.10 | 0.4774 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2432.15 and 2533.75
| Monthly Target 1 | 2414.23 |
| Monthly Target 2 | 2450.07 |
| Monthly Target 3 | 2515.8333333333 |
| Monthly Target 4 | 2551.67 |
| Monthly Target 5 | 2617.43 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Wed 04 March 2026 | 2485.90 (-3.33%) | 2520.00 | 2480.00 - 2581.60 | 0.089 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.8575 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.766 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.2519 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.0442 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.678 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 1.0801 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.4947 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 0.9126 times | Mon 30 June 2025 | 3388.10 (2.71%) | 3298.00 | 3153.90 - 3515.70 | 1.8259 times | Fri 30 May 2025 | 3298.60 (11.27%) | 2935.30 | 2693.90 - 3398.00 | 3.2789 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2353.1 and 2852.6
| Yearly Target 1 | 1975.83 |
| Yearly Target 2 | 2230.87 |
| Yearly Target 3 | 2475.3333333333 |
| Yearly Target 4 | 2730.37 |
| Yearly Target 5 | 2974.83 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Wed 04 March 2026 | 2485.90 (0.5%) | 2476.00 | 2220.30 - 2719.80 | 0.1725 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.6665 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.267 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2602 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.732 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9764 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0896 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4661 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2371 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1326 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1328 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in uptrend. But this trend seems to be weakening.
Price is below an important level of 2570.03 on charts, and if price remains below this level, then stock might show a fall in short term.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO is bearish. The stock has broken weekly support. An up move can be expected only after it starts trading above 2517.4
Munafa value: 40 as on Wed 04 March 2026
This Munafa value indicates that the stock is moving downwards and might continue to move down.
SMA20 is at 2577 and price is deviating by 75 points
Upper Bollinger band is at 2725 and lower is at 2428, while middle bands are at 2502 and 2651
Price is coming down
Price is below 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for GlaxosmithklinePharmaceuticals in short term but the sell signal is initial and weak.
GlaxosmithklinePharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2580.88 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2573.72 |
| 12 day DMA | 2590.41 |
| 20 day DMA | 2576.1 |
| 35 day DMA | 2485.7 |
| 50 day DMA | 2476.33 |
| 100 day DMA | 2537.32 |
| 150 day DMA | 2622.56 |
| 200 day DMA | 2774.24 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2550.29 | 2582.48 | 2607.42 |
| 12 day EMA | 2570.05 | 2585.35 | 2594.94 |
| 20 day EMA | 2556.41 | 2563.83 | 2567.12 |
| 35 day EMA | 2533.33 | 2536.12 | 2536.33 |
| 50 day EMA | 2492.73 | 2493.01 | 2491.39 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2573.72 | 2600.18 | 2621.38 |
| 12 day SMA | 2590.41 | 2599.45 | 2610.78 |
| 20 day SMA | 2576.1 | 2573.57 | 2567.3 |
| 35 day SMA | 2485.7 | 2483.17 | 2478.58 |
| 50 day SMA | 2476.33 | 2477.19 | 2477.62 |
| 100 day SMA | 2537.32 | 2539.76 | 2541.83 |
| 150 day SMA | 2622.56 | 2626.95 | 2631.15 |
| 200 day SMA | 2774.24 | 2775.96 | 2777.69 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 56.39 and PE is: 44.08
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
EPS is 56.09 and PE is: 44.32
Last quarter profit: (June 2025 quarter) 205.01 crores (12.44%)
Debt: 9.95 in crores
Market capitalization: 47197.61
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
